Palavras-chave
TAVR
MIARV
Tratamento
Prognóstico
Como Citar
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Resumo
Objetivo: Examinar as evidências disponíveis sobre as abordagens na estenose aórtica, incluindo a substituição valvar aórtica transcateter e a cirurgia valvar aórtica minimamente invasiva. Métodos: Trata-se de um estudo de revisão integrativa. As bases de dados utilizadas foram o PubMed e BVS. A busca pelos artigos foi realizada considerando os descritores “Transcatheter Aortic Valve Replacement”, “Aortic Valve Stenosis” e “Cardiovascular Surgical Procedures”, utilizando o operador booleano “AND”. Foram incluídos artigos publicados entre 2022-2023; em inglês; de acesso livre; do tipo estudo clínico, ensaio clínico, estudo observacional e ensaio clínico controlado. Resultados: Dos artigos analisados, vinte abordaram os benefícios e resultados positivos da TAVR. Esses estudos destacaram taxas de mortalidade reduzidas, bons resultados a curto e longo prazo e o TAVR como uma opção custo-efetiva. Entretanto, nove artigos discutiram as complicações e desafios associados ao TAVI. Problemas como desajuste prótese-paciente, anormalidades de condução, lesões renais agudas e distúrbios de coagulação. Ademais, três artigos relataram um benefício significativo quando utilizada a cirurgia convencional em pacientes obesos e pacientes com disfunção ventricular esquerda. Considerações finais: A TAVR é segura e eficaz, com baixa taxa de mortalidade. Por outro lado, a MIARV visa preservar e reparar a valva nativa oferecendo menor risco de complicações.
Referências
AIDIETIS A, et al. 30-Day and 1-Year Outcomes With HYDRA Self-Expanding Transcatheter Aortic Valve: The Hydra CE Study. JACC Cardiovasc Interv, 2022; 15(1): 93–104.
ALASNAG M, et al. One-Year Outcomes for Patients Undergoing Transcatheter Aortic Valve Replacement: The Gulf TAVR Registry. Cardiovasc Revasc Med, 2022; 41: 19–26.
BAUMGARTNER H, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal, 2017; 38(36): 2739–2791.
CHEN CG, et al. Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Low-risk Patients: A Meta-Analysis Based on a 2-Year Follow-Up. Anatol J Cardiol, 2022; 26(11): 802–809.
DISMORR M, et al. Effect of Prosthesis-Patient Mismatch on Long-Term Clinical Outcomes After Bioprosthetic Aortic Valve Replacement. Journal of the American College of Cardiology, 2023; 81(10): 964–975.
ESPOSITO G, et al. Predictors of post-TAVI conduction abnormalities in patients with bicuspid aortic valves. Open Heart, 2022; 9(2): e001995.
HARADA M, et al. Changes in platelet function and coagulation after transcatheter aortic valve implantation evaluated with thromboelastography. Open Heart, 2022; 9(2): e002132.
HUCZEK Z, et al. Transcatheter aortic valveinvalve implantation for failed surgical bioprostheses: results from the Polish Transcatheter Aortic Valve-in-Valve Implantation (ViVTAVI) Registry. Pol. Arch. Med. Wew. (Online), 2022; 132(2).
JALAVA MP, et al. Transcatheter and surgical aortic valve replacement in patients with left ventricular dysfunction. Journal of Cardiothoracic Surgery, 2022; 17(1): 322.
KANG SL, et al. Is there a role for endovascular stent implantation in the management of postoperative right ventricular outflow tract obstruction in the era of transcatheter valve implantation? Catheter Cardiovasc Interv, 2022; 99(4): 1138–1148.
KORCZAK A, et al. Acute kidney injury as the most important predictor of poor prognosis after interventional treatment for aortic stenosis. Kardiol Pol, 2022; 80(10): 1032–1038.
KUCK KH, et al. Cost-Effectiveness of SAPIEN 3 Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in German Severe Aortic Stenosis Patients at Low Surgical Mortality Risk. Adv Ther, 2023; 40(3): 1031–1046.
LANGE T, et al. Functional and structural reverse myocardial remodeling following transcatheter aortic valve replacement: a prospective cardiovascular magnetic resonance study. Journal of Cardiovascular Magnetic Resonance: Official Journal of the Society for Cardiovascular Magnetic Resonance, 2022; 24(1): 45.
MAGRO PL e SOUSA-UVA M. In low-risk patients aged >70-75 with severe aortic stenosis, is transcatheter superior to surgical aortic valve replacement in terms of reported cardiovascular composite outcomes and survival? Interact Cardiovasc Thorac Surg, 2022; 34(1): 40–44.
MAILEY JA, et al. Reframing Optimal Implantation of the Sapien 3 Transcatheter Heart Valve. The Journal of Invasive Cardiology, 2022; 34(5): 380–389.
MAJMUNDAR M, et al. Early outcomes of transcatheter versus surgical aortic valve implantation in patients with bicuspid aortic valve stenosis. EuroIntervention, 2022; 8(1): 23–32.
MCINERNEY A, et al. Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis. EuroIntervention, 2022; 18(5): 417–427.
MEDRANDA GA, et al. Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2022; 18(5): 407–416.
MUNERETTO C, et al. Sutureless versus transcatheter aortic valves in elderly patients with aortic stenosis at intermediate risk: A multi-institutional study. J Thorac Cardiovasc Surg, 2022; 163(3): 925- 935.
NARDI G, et al. Peripheral intravascular lithotripsy for transcatheter aortic valve implantation: a multicentre observational study. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2022; 17(17): 1397–1406.
OKUNO T, et al. Transcatheter aortic valve implantation in patients with rheumatic aortic stenosis. Heart, 2022; 108(15): 1225–1233.
OLIEMY A e AL-ATTAR N. Transcatheter aortic valve implantation. F1000Prime Reports, 2014; 6: 92.
PEREIRA AS, et al. Metodologia da pesquisa científica. [s.l.] Brasil, 2018.
RAM E, et al. Frailty and clinical outcomes following aortic valve replacement. Journal of Cardiac Surgery, 2022; 37(10): 3036–3043.
RIZIK DG, et al. Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical Trial. JAMA network open, 2022; 5(10): e2238792.
ROBERTSON DM, et al. Transcatheter and Surgical Aortic Valve Implantation in Children, Adolescents, and Young Adults With Congenital Heart Disease. Am J Cardiol, 2022; 177: 128–136.
SÁ MP, et al. Late Outcomes After Aortic Root Enlargement During Aortic Valve Replacement: Meta-Analysis With Reconstructed Time-To-Event Data. J Cardiothorac Vasc Anesth, 2022; 36(8): 3065–3073.
SIQUEIRA DAA, et al. Single-center experience with merils myval transcatheter heart valve. J. Transcatheter Interv, 2022; 30(1): 100–101.
TARASOUTCHI F, et al. Atualização das Diretrizes Brasileiras de Valvopatias – 2020. Arquivos Brasileiros de Cardiologia, 2020; 115(4): 720–775.
THADEN JJ, et al. Sex-related differences in calcific aortic stenosis: correlating clinical and echocardiographic characteristics and computed tomography aortic valve calcium score to excised aortic valve weight. European Heart Journal, 2016; 37(8): 693–699.
TOMALA O, et al. Comparison of outcomes of trans-subclavian versus trans-apical approaches in transcatheter aortic valve implantation. Journal of Cardiothoracic Surgery, 2022; 17(1): 180.
TOMII D, et al. Long-term outcomes of new-onset conduction abnormalities following transcatheter aortic valve implantation. Archives of Cardiovascular Diseases, 2022; 115(4): 214–224.
TOMII D, et al. Impact of First-Phase Ejection Fraction on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation. Cardiovascular Revascularization Medicine: Including Molecular Interventions, 2022; 42: 55–61.
INVESTIGATORS UTT, et al. Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic Stenosis: A Randomized Clinical Trial. JAMA, 2022; 327(19): 1875–1887.
WILLIAMS MR, et al. The PARTNER 3 Bicuspid Registry for Transcatheter Aortic Valve Replacement in Low-Surgical-Risk Patients. JACC Cardiovasc Interv, 2022; 15(5): 523–532.